REG - Unbound Group PLC - Rule 2.9 Announcement

UnboundAnnouncement

19/05/2023 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230519:nRSS0521Aa&default-theme=true

RNS Number : 0521A  Unbound Group PLC  19 May 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

19 May 2023

 

Unbound Group plc

("Unbound", the "Company" or the "Group")

Rule 2.9 Announcement

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the
"Code"), Unbound confirms that, as at the date of this announcement, it has
65,155,980 ordinary shares of 1 pence each in issue and admitted to trading on
the AIM market of the London Stock Exchange (and holds no shares in
treasury). Therefore, the total number of shares with full voting rights in
the Company at the above date is 65,155,980.

 

The International Securities Identification Number (ISIN) for the Company's
ordinary shares is GB0003085445.

 

Enquiries

 

 

 Unbound Group plc                                                           c/o Alma PR

 Ian Watson, CEO

 Gavin Manson, CFO
 Singer Capital Markets (Financial Adviser, Nominated Adviser & Broker)        +44 (0)20 7496 3000

 Peter Steel / Tom Salvesen / Alaina Wong / James Fischer
 Interpath Advisory Ltd (Joint Financial Adviser)                              +44 (0)20 3989 2800

 Will Wright / Andrew Stone / Jack Brazier
 Alma PR Limited (Financial PR)                                              +44 (0) 20 3405 0205

 Josh Royston / Sam Modlin / Hannah Campbell                                 unbound@almapr.co.uk (mailto:unbound@almapr.co.uk)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RTTEAESNFEDDEFA